Breaking News Instant updates and real-time market news.

KIDS

OrthoPediatrics

$37.38

0.38 (1.03%)

07:13
02/20/19
02/20
07:13
02/20/19
07:13

OrthoPediatrics initiated with an Outperform at JMP Securities

JMP Securities analyst David Turkaly initiated OrthoPediatrics with an Outperform rating and $44 price target, stating that the company has limited competition since the pediatric market has been widely overlooked by large medical device players. He expects year-over-year sales growth to continue at over 20% through 2020 given the company's robust product portfolio, secular emphasis on new system launches and set deployment, and planned sales force additions, said Turkaly, who adds that OrthoPediatrics "maintains a very solid margin profile."

  • 20

    Feb

  • 21

    Feb

  • 26

    Mar

  • 27

    Mar

KIDS OrthoPediatrics
$37.38

0.38 (1.03%)

10/19/18
PIPR
10/19/18
NO CHANGE
PIPR
Overweight
FDA approval closes gap in OrthoPediatrics spine franchise, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien said OrthoPediatrics' announcement of FDA approval of their small stature scoliosis spine system was in-line with expectations from a timing perspective, adding that the system closes a gap in the company's spine franchise. O'Brien, who thinks the primary benefit of the new system should come during the primary scoliosis season in Q2 and Q3 of 2019, expects it will help sustain or even accelerate growth in this segment. The analyst keeps an Overweight rating on OrthoPediatrics shares, adding that he views the company as "truly unique."
11/01/18
PIPR
11/01/18
NO CHANGE
Target $35
PIPR
Overweight
OrthoPediatrics should be bought on weakness, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien notes that OrthoPediatrics reported top-line growth of 28% in the quarter ahead of consensus and raised full-year guidance by 175bps at the midpoint. After normalizing some non-recurring professional fees, EPS was in-line with expectations, while EBITDA was ahead of his estimates. Overall, the analyst believes management continues to execute upon its growth strategy with consistent top-line momentum that makes it a unique name within orthopedics, and investors should take advantage of the weakness in the shares. He reiterates an Overweight rating on the stock, while raising his price target on the shares to $35 from $33.
12/12/18
PIPR
12/12/18
NO CHANGE
Target $35
PIPR
Overweight
OrthoPediatrics capital raise positive signal for sales, says Piper Jaffray
Following yesterday's secondary offering, OrthoPediatrics has $65M of cash available, providing greater financial flexibility throughout 2019 regarding the timing and amount of instrument sets deployed, Piper Jaffray analyst Matt O'Brien tells investors in a research note. The analyst adds that with instrument set availability the largest "gating factor" for the company's growth, he views the capital raise as a positive signal for the company's sales outlook. He reiterates an Overweight rating on OrthoPediatrics and continues to believe that investors "should own this unique asset."
01/02/19
BTIG
01/02/19
NO CHANGE
Target $37
BTIG
Buy
OrthoPediatrics price target raised to $37 at BTIG
BTIG analyst Ryan Zimmerman raised his price target on OrthoPediatrics to $37 and kept his Buy rating, calling the stock his "2019 Top Pick in Musculoskeletal" sector. The analyst points to a "combination of durable demographic and epidemiological trends, stable procedural volumes within hospitals, and a robust economy spurring elective procedure demand" supporting the sector's continued growth. Zimmerman is also positive on the company's "strengthened balance sheet from a recent equity raise, a large total addressable market, limited competition, and a growing portfolio of niche products."

TODAY'S FREE FLY STORIES

ARNC

Arconic

$27.14

-0.17 (-0.62%)

16:55
09/19/19
09/19
16:55
09/19/19
16:55
Hot Stocks
Arconic to sell forgings business in U.K. to Aero Forgings for roughly $62M »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

DOVA

Dova Pharmaceuticals

$16.00

0.5 (3.23%)

, RIGL

Rigel Pharmaceuticals

$1.71

0.015 (0.89%)

16:55
09/19/19
09/19
16:55
09/19/19
16:55
Conference/Events
Wedbush biotech analysts to hold a dinner meeting »

Biotech Analysts…

DOVA

Dova Pharmaceuticals

$16.00

0.5 (3.23%)

RIGL

Rigel Pharmaceuticals

$1.71

0.015 (0.89%)

ARGX

Argenx

$126.44

-0.94 (-0.74%)

MNTA

Momenta

$13.35

-0.14 (-1.04%)

AMGN

Amgen

$195.64

0.67 (0.34%)

NVS

Novartis

$86.39

0.09 (0.10%)

ALNY

Alnylam

$84.68

-0.87 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 24

    Oct

  • 04

    Feb

BYND

Beyond Meat

$155.04

1.31 (0.85%)

, TSLA

Tesla

$246.51

3.08 (1.27%)

16:48
09/19/19
09/19
16:48
09/19/19
16:48
Hot Stocks
Beyond Meat names Sanjay Shah COO »

Beyond Meat (BYND)…

BYND

Beyond Meat

$155.04

1.31 (0.85%)

TSLA

Tesla

$246.51

3.08 (1.27%)

AMZN

Amazon.com

$1,822.21

4.21 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Oct

  • 12

    Nov

SMTX

SMTC Corp.

$2.96

0.16 (5.71%)

16:40
09/19/19
09/19
16:40
09/19/19
16:40
Earnings
SMTC Corp. guides initial FY20 revenue $390M-$410M, two estimate $421.85M »

Guides initial FY20…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CLXT

Calyxt

$6.97

-0.2 (-2.79%)

16:40
09/19/19
09/19
16:40
09/19/19
16:40
Hot Stocks
Calyxt signs seed agreement with Landus Cooperative in Iowa »

Calyxt has added Landus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SMTX

SMTC Corp.

$2.96

0.16 (5.71%)

16:39
09/19/19
09/19
16:39
09/19/19
16:39
Earnings
SMTC Corp to exit China operations, cuts FY19 revenue view to $354M-$362M »

Two estimates $392.79M. …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ACRGF

Acreage Holdings

$0.00

(0.00%)

16:36
09/19/19
09/19
16:36
09/19/19
16:36
Initiation
Acreage Holdings initiated  »

Acreage Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMTX

SMTC Corp.

$2.96

0.16 (5.71%)

16:36
09/19/19
09/19
16:36
09/19/19
16:36
Hot Stocks
Breaking Hot Stocks news story on SMTC Corp. »

SMTC Corp to exit China…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

16:35
09/19/19
09/19
16:35
09/19/19
16:35
General news
Money Supply M2 Weekly Change data reported »

Week of 9/9 Money Supply…

16:35
09/19/19
09/19
16:35
09/19/19
16:35
General news
Fed Balance Sheet Level data reported »

Week of 9/18 Fed Balance…

FSLR

First Solar

$67.09

1.32 (2.01%)

16:35
09/19/19
09/19
16:35
09/19/19
16:35
Hot Stocks
First Solar transitions to leveraging third-party EPC services »

First Solar, Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEXO

HEXO Corp

$3.94

-0.175 (-4.25%)

16:35
09/19/19
09/19
16:35
09/19/19
16:35
Initiation
HEXO Corp initiated  »

HEXO Corp initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CURLF

Curaleaf Holdings

$0.00

(0.00%)

16:34
09/19/19
09/19
16:34
09/19/19
16:34
Initiation
Curaleaf Holdings initiated  »

Curaleaf Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CHNR

China Natural Resources

$2.53

0.13 (5.42%)

16:34
09/19/19
09/19
16:34
09/19/19
16:34
Syndicate
Breaking Syndicate news story on China Natural Resources »

China Natural Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEY

KeyCorp

$18.04

-0.18 (-0.99%)

16:32
09/19/19
09/19
16:32
09/19/19
16:32
Hot Stocks
KeyCorp CEO Beth Mooney to retire »

KeyCorp announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ASA

ASA Limited

$12.56

0.25 (2.03%)

16:31
09/19/19
09/19
16:31
09/19/19
16:31
Hot Stocks
ASA Limited reports NAV positive 59.4% for 9 months ended August 31 »

ASA Gold and Precious…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
09/19/19
09/19
16:30
09/19/19
16:30
Options
Preliminary option volume of 20.3M today »

Preliminary option volume…

NDLS

Noodles & Company

$5.92

-0.05 (-0.84%)

16:29
09/19/19
09/19
16:29
09/19/19
16:29
Hot Stocks
Noodles & Company names Jeffrey Jones as board chairman »

Noodles & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRY

Tilray

$29.91

-0.59 (-1.93%)

16:29
09/19/19
09/19
16:29
09/19/19
16:29
Initiation
Tilray initiated  »

Tilray initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

MSFT

Microsoft

$141.08

2.55 (1.84%)

, TGT

Target

$107.84

0.92 (0.86%)

16:29
09/19/19
09/19
16:29
09/19/19
16:29
On The Fly
Fly Intel: Wall Street's top stories for Thursday »

Stocks spent the morning…

MSFT

Microsoft

$141.08

2.55 (1.84%)

TGT

Target

$107.84

0.92 (0.86%)

MO

Altria Group

$40.12

-0.72 (-1.76%)

PM

Philip Morris

$71.70

0.12 (0.17%)

GE

General Electric

$9.41

0.03 (0.32%)

CBPO

China Biologic

$113.97

10.78 (10.45%)

MLHR

Herman Miller

$45.05

0.57 (1.28%)

X

U.S. Steel

$11.06

-1.39 (-11.16%)

GRUB

GrubHub

$60.54

-3.245 (-5.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 23

    Sep

  • 25

    Sep

  • 21

    Oct

  • 22

    Oct

  • 27

    Oct

  • 30

    Oct

PGR

Progressive

$75.77

0.57 (0.76%)

16:28
09/19/19
09/19
16:28
09/19/19
16:28
Hot Stocks
Progressive's Chief Investment Officer William Cody retiring, succesor appointed »

Progressive appointed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$26.33

-2.49 (-8.64%)

16:28
09/19/19
09/19
16:28
09/19/19
16:28
Initiation
Canopy Growth initiated  »

Canopy Growth initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

CRON

Cronos Group

$10.23

-0.725 (-6.62%)

16:28
09/19/19
09/19
16:28
09/19/19
16:28
Initiation
Cronos Group initiated  »

Cronos Group initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACB

Aurora Cannabis

$5.16

-0.11 (-2.09%)

16:27
09/19/19
09/19
16:27
09/19/19
16:27
Initiation
Aurora Cannabis initiated  »

Aurora Cannabis initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Sep

AWK

American Water

$122.48

1.01 (0.83%)

16:26
09/19/19
09/19
16:26
09/19/19
16:26
Hot Stocks
Illinois American Water acquires Village of Glasford water, wastewater systems »

Illinois American Water…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.